184 related articles for article (PubMed ID: 11714810)
21. Identification of domain boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-mediated increase in peptide loading of MHC class I.
Procko E; Raghuraman G; Wiley DC; Raghavan M; Gaudet R
Immunol Cell Biol; 2005 Oct; 83(5):475-82. PubMed ID: 16174096
[TBL] [Abstract][Full Text] [Related]
22. Tobacco reduces membrane HLA class I that is restored by transfection with transporter associated with antigen processing 1 cDNA.
Fine CI; Han CD; Sun X; Liu Y; McCutcheon JA
J Immunol; 2002 Nov; 169(10):6012-9. PubMed ID: 12421988
[TBL] [Abstract][Full Text] [Related]
23. Peptide selection for presentation by HLA class I: a role for the human transporter associated with antigen processing?
van Endert PM
Immunol Res; 1996; 15(4):265-79. PubMed ID: 8988395
[TBL] [Abstract][Full Text] [Related]
24. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
25. Intramembrane proteolysis and post-targeting functions of signal peptides.
Martoglio B
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1243-7. PubMed ID: 14641034
[TBL] [Abstract][Full Text] [Related]
26. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
Skipper JC; Kittlesen DJ; Hendrickson RC; Deacon DD; Harthun NL; Wagner SN; Hunt DF; Engelhard VH; Slingluff CL
J Immunol; 1996 Dec; 157(11):5027-33. PubMed ID: 8943411
[TBL] [Abstract][Full Text] [Related]
27. TAP-independent presentation of CTL epitopes by Trojan antigens.
Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
[TBL] [Abstract][Full Text] [Related]
28. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
29. Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum.
Fruci D; Niedermann G; Butler RH; van Endert PM
Immunity; 2001 Sep; 15(3):467-76. PubMed ID: 11567636
[TBL] [Abstract][Full Text] [Related]
30. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
[TBL] [Abstract][Full Text] [Related]
31. Assembly of tapasin-associated MHC class I in the absence of the transporter associated with antigen processing (TAP).
Paulsson KM; Anderson PO; Chen S; Sjögren HO; Ljunggren HG; Wang P; Li S
Int Immunol; 2001 Jan; 13(1):23-9. PubMed ID: 11133831
[TBL] [Abstract][Full Text] [Related]
32. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
33. Human T cell receptor-mediated recognition of HLA-E.
García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
[TBL] [Abstract][Full Text] [Related]
34. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
35. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
O'Callaghan CA; Tormo J; Willcox BE; Braud VM; Jakobsen BK; Stuart DI; McMichael AJ; Bell JI; Jones EY
Mol Cell; 1998 Mar; 1(4):531-41. PubMed ID: 9660937
[TBL] [Abstract][Full Text] [Related]
36. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
Lee N; Malacko AR; Ishitani A; Chen MC; Bajorath J; Marquardt H; Geraghty DE
Immunity; 1995 Nov; 3(5):591-600. PubMed ID: 7584149
[TBL] [Abstract][Full Text] [Related]
37. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
Braud V; Jones EY; McMichael A
Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
[TBL] [Abstract][Full Text] [Related]
38. Conserved MHC class I peptide binding motif between humans and rhesus macaques.
Dzuris JL; Sidney J; Appella E; Chesnut RW; Watkins DI; Sette A
J Immunol; 2000 Jan; 164(1):283-91. PubMed ID: 10605022
[TBL] [Abstract][Full Text] [Related]
39. Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1.
Minev BR; Chavez FL; Dudouet BM; Mitchell MS
Eur J Immunol; 2000 Aug; 30(8):2115-24. PubMed ID: 10940901
[TBL] [Abstract][Full Text] [Related]
40. T cell recognition of an HLA-A2-restricted epitope derived from a cleaved signal sequence.
Guéguen M; Biddison WE; Long EO
J Exp Med; 1994 Nov; 180(5):1989-94. PubMed ID: 7525846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
